(Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Sepsis Diagnostics Market Size, Share & Trends Analysis - Global opportunity analysis and industry forecast 2030

Sepsis Diagnostics Market Size, Share & Trends Analysis - Global...

Home / Categories / Healthcare
Sepsis Diagnostics Market Size, Share & Trends Analysis - Global opportunity analysis and industry forecast 2030
Sepsis Diagnostics Market Size, Share...
Report Code

Publish Date

$ 4950/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 6250/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

The global sepsis diagnostics market was valued at US $54 million in the year 2020 and is expected to be worth at US $142 billion by the year 2030. The market is thriving at a compound annual growth rate (CAGR) of 10.2% during the year from 2021 to 2030.

Septicemia, also known as sepsis or septic shock, is a clinical and medical condition caused by the body's attempt to fight off an infection. It is a very serious and possibly deadly condition where the human body tries to fight the infection by releasing chemicals causing inflammation while the infection spreads into the bloodstream, this causes inflammation. The infection flowing in the bloodstream can reach vital organs, which then may require surgery to get rid of tissue damaged by the infection. Due to these reasons, sepsis needs urgent medical attention and treatment.

Factors Affecting

  • The rising number of cases in deadly conditions such as sepsis and large funding invested by private institutions for accurate diagnosis and treatment has resulted in increasing demand for global sepsis diagnostics market.
  • With improved technology, many healthcare institutions are starting to use better and improved technology for diagnosing diseases like sepsis, which will result is increasing demand.
  • Sepsis can be caused by external factors such as viruses, bacteria and other pathogens getting into the body in many ways, one of them being hospital-acquired infections (HAIs). There has been a rise in the number of HAIs ever since the spread of Covid-19 pandemic, which is contributing to the rise in demand for sepsis diagnostics market worldwide. 
  • The devices used for finding out and diagnosing sepsis are very expensive and requires huge amounts of investment in adopting such technology, which can prove to be an obstacle for healthcare infrastructure especially in developing countries and may slow down the market growth. 

Impact of Covid-19

The covid-19 pandemic has been a boost for the global sepsis diagnostics market. Experts say, that patients infected with Covid-19 are at a higher risk of kidney failure, sepsis and pneumonia. Ever since the pandemic, the number of sepsis cases has increased, such a sudden rise in sepsis cases has put a lot of stress on healthcare infrastructure. Due to such reasons, the demand for sepsis diagnosis market has increased globally.

Regional Insights

According to region, North America is leading the global sepsis diagnostics market. This is due to their acceptance in the use of advanced medical facilities and healthcare infrastructure. There is a quick rise in the number of sepsis cases among the American people. Moreover, they have a high number of market competitors in the global sepsis diagnostics market. Such factors are contributing to the growth in demand for the sepsis diagnostics market worldwide.

Leading Competitors

The leading and prominent competitors in the global sepsis diagnostics market are:

  • Abbott Laboratories
  • Axis-Shield Diagnostics
  • Becton Dickinson Company
  • bioMérieux
  • Bruker Corporation
  • Danaher
  • EKF Diagnostics
  • Genmark Diagnostics
  • Immunexpress Inc.
  • Response Biomedical
  • Roche Diagnostics
  • T2 Biosystems
  • Thermo Fisher Scientific
  • Other Prominent Players

Scope of the Report

The global sepsis diagnostics market can be segmented on the basis of Pathogen, Technology, Test Type, Product, Method, End User and Region

By Pathogen

  • Bacterial Sepsis
    • Gram-Negative Bacterial Sepsis
    • Gram-Positive Bacterial Sepsis
  • Fungal Sepsis
  • Other Pathogen

By Technology

  • Blood Culture
  • Immunoassays
  • Molecular Diagnostics
    • PCR
    • Peptide Nucleic Acid-Fluorescent In Situ Hybridization
    • Microarrays
    • Syndromic Panel-Based Testing
  • Flow Cytometry
  • Microfluidics
  • Biomarkers

By Test Type

  • Laboratory Tests
  • Point-of-Care Tests

By Product

  • Blood Culture Media
  • Assays & Reagents
  • Instruments
  • Software

By Method

  • Automated Diagnostics
  • Conventional Diagnostics

By End-User

  • Hospitals
  • Pathology & Reference Laboratories
  • Research Laboratories & Academic Institutes

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA
  • South America
  • Brazil
  • Argentina
  • Rest of South America


500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES